市場調査レポート

商品コード

1593504

バイオチップの市場規模・シェア・成長分析 (種類別、製造技術別、用途別、エンドユーザー別、地域別)：産業予測 (2024～2031年)

Biochips Market Size, Share, Growth Analysis, By Type (DNA Chips, Lab-On-A-Chip), By Fabrication Technology (Microarrays, Microfluidics), By Application (Genomics, Drug Development), By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

世界のバイオチップの市場規模は、2022年に95億3,000万米ドルと評価され、2023年の107億4,000万米ドルから2031年には279億1,000万米ドルに成長し、予測期間中 (2024～2031年) に12.68%のCAGRで成長する見通しです。

ラボオンチップおよびマイクロアレイ (バイオチップ) 市場は、新型コロナウイルス感染症 (COVID-19) 感染拡大が大きな原動力となり、ウイルスに関連する診断や研究におけるこれらの技術に対する需要が増幅され、著しい急成長を遂げています。今後は、PoC検査ソリューションに対する需要の増加、慢性疾患の流行の高まり、がん研究におけるプロテオミクスとゲノミクスの応用拡大などに後押しされ、市場は成長軌道を維持するものと思われます。この市場拡大の主な要因としては、主要企業による先進的診断検査の開発、世界の慢性疾患の負荷、プロテオミクス研究におけるバイオチップの利用拡大などが挙げられます。慢性疾患は、特に高齢化社会の障害や死亡率の主な原因となっており、効果的な診断のためのラボオンチップベースシステムの研究や技術革新の原動力となっています。さらにバイオチップは、バイオマーカーや創薬の取り組みに不可欠となる、サンプル要求量の縮小や包括的プロテオーム解析促進能力などの利点により、生物医学やバイオテクノロジーの分野で支持を集めています。特筆すべきは、COVID-19に対する特許取得済みの診断アッセイを含む革新的な製品の承認が市場力学にプラスの影響を与え、その強固な成長可能性が強化されたことです。バイオチップ技術や診断用途の進歩が進むにつれ、この急成長市場において利害関係者には十分なビジネスチャンスが生まれると思われます。

市場概要
DNAチップ
- 遺伝子発現
- SNPジェノタイピング
- がん診断・治療
- ゲノミクス
- 創薬
- 農業バイオテクノロジー
- その他のDNAチップの用途
ラボオンチップ (LOAC)
- 臨床診断
- ゲノミクス
- IVD・PoC
- プロテオミクス
- 創薬
- その他のラボオンチップの用途
タンパク質チップチップ
- プロテオミクス
- 発現プロファイリング
- 診断
- ハイスループットスクリーニング
- 創薬
- その他のタンパク質チップの用途
その他のアレイ
- 細胞アレイ
- 組織アレイ

バイオチップ市場：製造技術別

市場概要
マイクロアレイ
マイクロ流体

バイオチップ市場：用途別

市場概要
ゲノミクス
医薬品開発
農業
その他

バイオチップ市場：エンドユーザー別

市場概要
バイオテクノロジー・製薬企業
病院・診断センター
学術調査機関
その他のエンドユーザー

バイオチップ市場：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ
中東・アフリカ (MEA)
- 湾岸協力会議 (GCC) 諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング (2023年)
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア (2023年)

主要企業プロファイル

Abbott Laboratories
Agilent Technologies, Inc.
PerkinElmer, Inc.
Standard BioTools Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Micronit Microtechnologies
Randox Laboratories Ltd.
RayBiotech, Inc.
Invitae
CapitalBio Corporation
Genscript Biotech Corp
Takara Bio Usa Holdings, Inc.

Product Code: SQMIG45A2235

Global Biochips Market size was valued at USD 9.53 billion in 2022 and is poised to grow from USD 10.74 billion in 2023 to USD 27.91 billion by 2031, growing at a CAGR of 12.68% during the forecast period (2024-2031).

The lab-on-a-chip and microarrays (biochips) market is witnessing a significant surge, largely driven by the COVID-19 pandemic, which amplified the demand for these technologies in diagnostics and research related to the virus. As we move forward, the market is set to continue its growth trajectory, propelled by the increasing demand for point-of-care testing solutions, the rising prevalence of chronic diseases, and the expanding application of proteomics and genomics in cancer research. Key factors contributing to this market expansion include a strong focus on the development of advanced diagnostic tests by leading companies, the global burden of chronic diseases, and the growing utilization of biochips in proteomics studies. Chronic diseases remain a major contributor to disability and mortality rates, particularly among the aging population, driving research and innovation in lab-on-a-chip-based systems for effective diagnosis. Furthermore, biochips are gaining traction within biomedical and biotechnological sectors due to their advantages, such as lower sample requirements and their ability to facilitate comprehensive proteome analyses, crucial for biomarker and drug discovery initiatives. Notably, the approval of innovative products, including patented diagnostic assays for COVID-19, has positively influenced market dynamics, reinforcing its robust growth potential. As the landscape evolves, the ongoing advancements in biochip technology and diagnostic applications are set to create ample opportunities for stakeholders in this burgeoning market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Biochips market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biochips Market Segmental Analysis

Global Biochips Market is segmented by Type, Fabrication Technology, Application, End User, and Region. Based on Type, the market is segmented into DNA Chips (Gene Expression, SNP Genotyping, Cancer Diagnosis & Treatment, Genomics, Drug Discovery, Agricultural Biotechnology, Other DNA Chip Applications), Lab-On-A-Chip (Clinical Diagnostics, Genomics, IVD & POC, Proteomics, Drug Discovery, Other Loac Applications), Protein Chips (Proteomics, Expression Profiling, Diagnostics, High-Throughput Screening, Drug Discovery, Other Protein Chip Applications), Other Arrays (Cell Arrays, Tissue Arrays). Based on Fabrication Technology, the market is segmented into Microarrays, Microfluidics. Based on Application, the market is segmented into Genomics, Drug Development, Agriculture, and Others. Based on End User, the market is segmented into Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Biochips Market

The ongoing advancements in genomics and proteomics are significant market drivers for the Global Biochips market, as they enable deeper insights into individual genetic profiles and disease mechanisms. The escalating demand for personalized medicine is prompting healthcare providers to seek targeted and tailored medical interventions, where biochips are essential. These devices facilitate the rapid and efficient analysis of vast datasets, allowing for the identification of critical genetic mutations and biomarkers linked to various diseases. Consequently, the enhancement of patient outcomes through personalized treatment plans is propelling the adoption of biochips in clinical settings, further stimulating market growth.

Restraints in the Global Biochips Market

The Global Biochips market faces significant restraints primarily due to the high costs associated with the development and implementation of advanced biochip technologies. Creating accurate and reliable biochips demands substantial financial investment and lengthy development timelines, which can deter potential manufacturers and users alike. Furthermore, integrating these sophisticated devices into existing healthcare systems and laboratory environments often necessitates additional capital outlay for infrastructure upgrades and maintenance. These financial burdens may hinder some healthcare facilities from adopting biochips widely. Nevertheless, as technological innovations continue to emerge and production efficiencies improve, the associated costs are likely to decrease, fostering greater market acceptance over time.

Market Trends of the Global Biochips Market

The Global Biochips market is witnessing a significant trend towards personalized medicine and precision diagnostics, driven by rapid advancements in genomics and proteomics. As healthcare evolves, the demand for customized medical treatments based on individual genetic profiles is intensifying. Biochips, known for their capacity to process large volumes of genetic and protein data, are central to this transformation. Their integration with cutting-edge technologies like artificial intelligence and machine learning enhances the development of advanced diagnostic tools and tailored therapeutic solutions. This trend is facilitating more accurate identification of genetic mutations and disease biomarkers, ultimately fostering improved patient outcomes and driving market growth.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Technology Analysis
Patent Analysis
Regulatory Landscape
PESTEL Analysis

Biochips Market, By Type

Market Overview
DNA Chips
- Gene Expression
- SNP Genotyping
- Cancer Diagnosis & Treatment
- Genomics
- Drug Discovery
- Agricultural Biotechnology
- Other DNA Chip Applications
Lab-On-A-Chip
- Clinical Diagnostics
- Genomics
- IVD & POC
- Proteomics
- Drug Discovery
- Other Loac Applications
Protein Chips
- Proteomics
- Expression Profiling
- Diagnostics
- High-Throughput Screening
- Drug Discovery
- Other Protein Chip Applications
Other Arrays
- Cell Arrays
- Tissue Arrays

Biochips Market, By Fabrication Technology

Market Overview
Microarrays
Microfluidics

Biochips Market, By Application

Market Overview
Genomics
Drug Development
Agriculture
Others

Biochips Market, By End User

Market Overview
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Other End Users

Biochips Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Standard BioTools Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Micronit Microtechnologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayBiotech, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invitae
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CapitalBio Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Usa Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments